Mitochondria, Microglia, and the Immune System-How Are They Linked in Affective Disorders?

Area of Science:

• Neuroscience
• Immunology
• Metabolic research

Background:

• Major depressive disorder (MDD) is linked to immune system changes, including elevated pro-inflammatory cytokines and brain microglia activation.
• Mitochondrial dysfunction is increasingly implicated in MDD pathogenesis, affecting cellular functions and innate immunity.

Purpose of the Study:

• To review the intricate interplay between mitochondrial metabolism and innate immunity in the pathophysiology of MDD.
• To highlight immunometabolic processes governing microglial and myeloid cell functions in depression-associated neuroinflammation.

Main Methods:

• Literature review focusing on the interaction between mitochondrial function and immune responses in MDD.
• Analysis of studies examining rodent models of depression-like behavior and human MDD patients.
• Examination of microglial polarization and metabolic states in the context of depression.

Main Results:

• Mitochondrial perturbations can enhance cytokine production and neuroinflammation in depression models.
• Pro-inflammatory cytokines can negatively impact mitochondrial function, potentially worsening inflammation.
• Immunometabolic pathways involving microglia and myeloid cells are central to neuroinflammation in MDD.

Conclusions:

• Understanding immunometabolic pathways is crucial for identifying diagnostic markers and therapeutic targets for MDD.
• Mitochondrial metabolism and innate immunity are deeply interconnected in the development and progression of major depressive disorder.
• Microglial metabolic states and polarization are significant factors in depression-associated behavior and MDD pathophysiology.